Recombinant Saccharomyces cerevisiae Putative Uncharacterized Protein YGL149W (UniProt ID: P53116) is a 101-amino-acid protein encoded by the YGL149W gene in S. cerevisiae strain S288c. Despite its conserved presence across yeast strains, its biological function remains poorly characterized, though structural and interaction data suggest potential roles in cellular regulation or protein transport .
YGL149W has been identified in genome-wide coexpression networks and interaction studies:
CRM1p (β-karyopherin): Direct interaction with CRM1p, a nuclear export receptor involved in transporting proteins out of the nucleus .
Indirect Links: Coexpression with genes in pathways such as:
Conservation: Present in all S. cerevisiae strains but not essential for viability .
Expressional Patterns: Co-regulated with CMK1 (calmodulin-regulated protein kinase), suggesting a role in calcium-dependent signaling .
Lack of Functional Annotation: No confirmed biochemical activity or catalytic domain identified .
Limited Interactome Data: Only one confirmed interaction (CRM1p) reported to date .
Evolutionary Role: Conserved across yeast but absent in other eukaryotes, hinting at yeast-specific regulatory functions .
STRING: 4932.YGL149W
YGL149W is a putative uncharacterized protein from Saccharomyces cerevisiae (baker's yeast) with an amino acid sequence of GSVVTLLLLLFFCLFLLFFSLHFFCFTREHVHYTLPPKCHSLKFQFDSIPSSSLSLSPFPFLFFPRLRAVAFASPTLSFFFPI. The protein has an expression region spanning from amino acids 19-101, suggesting that the first 18 amino acids likely constitute a signal peptide or another regulatory element . The high proportion of hydrophobic amino acids (leucine, phenylalanine, isoleucine) in the sequence suggests potential membrane association, though further structural studies are required to confirm this hypothesis. Researchers should note that while the protein is uncharacterized, its conservation in yeast suggests evolutionary significance.
For optimal stability of recombinant YGL149W, store the lyophilized protein at -20°C or -80°C upon receipt. After reconstitution, working aliquots can be stored at 4°C for up to one week, but repeated freeze-thaw cycles should be avoided as they may compromise protein integrity . For long-term storage, it is recommended to add glycerol to a final concentration of 5-50% (with 50% being standard) and store aliquoted samples at -20°C/-80°C . The protein is typically supplied in a Tris/PBS-based buffer with 6% trehalose at pH 8.0, which helps maintain stability during freezing and thawing processes .
For proper reconstitution of YGL149W:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% for storage stability
Aliquot the reconstituted protein to minimize freeze-thaw cycles
Verify protein solubility and activity after reconstitution through appropriate assays
This methodological approach ensures maximum retention of protein functionality for downstream applications such as enzymatic assays, binding studies, or structural analyses.
When investigating uncharacterized proteins like YGL149W, a Completely Randomized Design (CRD) is often suitable for initial screening experiments conducted in controlled laboratory settings . This design is particularly useful when:
The experimental material is relatively homogeneous
You have a small number of treatments to compare
You want flexibility in the number of treatments or replications
The experiment is conducted in controlled laboratory conditions
For more complex studies where multiple factors might influence protein function, consider:
Randomized Block Design (RBD) when one additional factor needs to be controlled
Latin Square Design (LSD) when two additional factors need to be controlled
The key advantage of CRD for initial YGL149W characterization is that all variability among experimental units contributes to experimental error, allowing for a cleaner assessment of treatment effects in controlled environments .
Optimal replication strategies for YGL149W experiments should consider both biological and technical variability:
Determine appropriate number of replications based on:
Consider differential replication where more replications are allocated to treatments with:
For example, if studying four different treatments of YGL149W under varying conditions, you might allocate different numbers of replications (e.g., 3, 5, 6, and 6) based on these considerations, while ensuring the total number of experimental units is maintained .
A methodologically sound approach involves power analysis to determine the minimum number of replicates needed to detect significant effects at your desired confidence level, followed by proper randomization of experimental units to minimize bias.
For systematic functional characterization of YGL149W, a multi-omics approach is recommended:
Comparative Genomics Analysis:
Identify potential orthologs in related species
Analyze conserved domains and sequence motifs
Predict functional associations through phylogenetic profiling
Protein-Protein Interaction Studies:
Yeast two-hybrid screening using His-tagged YGL149W as bait
Co-immunoprecipitation followed by mass spectrometry
Proximity-labeling approaches (BioID or APEX)
Phenotypic Analysis:
Create YGL149W deletion/overexpression strains
Perform high-throughput phenotypic screening under various stress conditions
Assess growth curves, metabolic profiles, and morphological changes
Subcellular Localization:
Fluorescent tagging and microscopy
Subcellular fractionation and Western blotting
Correlation with predicted transmembrane domains based on the hydrophobic amino acid content
Given the hydrophobic nature of the YGL149W amino acid sequence, particular attention should be paid to potential membrane association and lipid interaction studies.
When encountering data inconsistencies in YGL149W studies:
Evaluate Experimental Design Factors:
Analyze Technical Variables:
Apply Statistical Approaches:
Implement Control Experiments:
Include well-characterized proteins as positive controls
Use empty vector or scrambled sequences as negative controls
Perform spike-in experiments to assess recovery and matrix effects
For reproducible results, document all experimental conditions comprehensively, including precise buffer compositions, incubation times and temperatures, and lot numbers of key reagents.
The optimal buffer conditions for YGL149W stability include:
When designing experiments, it's crucial to consider potential buffer incompatibilities with downstream applications. For instance, high glycerol concentrations may interfere with binding assays, while some detergents might affect spectroscopic measurements. Always perform buffer exchange using dialysis or size exclusion chromatography when transitioning between storage and experimental conditions.
To verify structural integrity of recombinant YGL149W, employ a combination of these analytical techniques:
When applying these techniques, establish appropriate positive controls using well-characterized proteins of similar size and properties to provide context for interpreting YGL149W results.
Statistical analysis for YGL149W experiments should follow these methodological principles:
Design-Appropriate Analysis:
Model Validation:
Verify assumptions of normality using Shapiro-Wilk or Kolmogorov-Smirnov tests
Check homogeneity of variance using Levene's or Bartlett's test
Assess independence of observations through residual plots
Effect Size Calculation:
Report partial eta-squared or Cohen's d values alongside p-values
Calculate confidence intervals for all estimates
Consider minimum detectable effect sizes in experimental planning
Multiple Testing Correction:
Apply Bonferroni, Šidák, or False Discovery Rate corrections when performing multiple comparisons
Report both unadjusted and adjusted p-values for transparency
To gain insights into YGL149W function through bioinformatics:
Sequence-Based Analysis:
Search for conserved domains using PFAM, SMART, or CDD
Predict secondary structure using PSIPRED or JPred
Identify signal peptides and transmembrane regions using SignalP and TMHMM
Assess post-translational modification sites using NetPhos, NetOGlyc, etc.
Structure Prediction:
Generate 3D models using AlphaFold2 or RoseTTAFold
Validate structural models using MolProbity
Identify potential binding pockets using CASTp or DoGSiteScorer
Perform molecular dynamics simulations to assess stability and flexibility
Functional Inference:
Query protein-protein interaction databases (STRING, BioGRID)
Analyze co-expression patterns using yeast microarray/RNA-seq datasets
Examine genetic interaction networks from genome-wide screens
Investigate phenotypes of deletion mutants in Saccharomyces Genome Database
Evolutionary Analysis:
Construct phylogenetic trees with orthologs from related species
Calculate selection pressure (dN/dS ratios) across different domains
Identify functionally important residues through evolutionary trace methods
These bioinformatic approaches should be considered complementary to experimental characterization, providing testable hypotheses rather than definitive functional assignments.